Products

Human Anti-PLP1(Anti-Proteolipid Protein 1, Myelin Antibody) ELISA Kit
One-click to copy product information
ELK8082
Size： Price：
48 T $320.00
96 T $458.00
Manual MSDS Send email to us

Overview

Product name: Human Anti-PLP1(Anti-Proteolipid Protein 1, Myelin Antibody) ELISA Kit
Reactivity: Human
Alternative Names: MMPL; PLP/DM20; PMD; SPG2; Pelizaeus-Merzbacher Disease; Spastic Paraplegia 2,Uncomplicated; Myelin proteolipid protein; Lipophilin
Assay Type: Competitive Inhibition
Sensitivity: 1.17 ng/mL
Standard: 200 ng/mL
Detection Range: 3.13-200 ng/mL
Sample type: Serum, plasma and other biological fluids.
Assay length: 2.5h
Research Area: Neuro science;
Test principle: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human Anti-PLP1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Anti-PLP1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Anti-PLP1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (ng/mL) OD Corrected OD
200.00 0.183
100.00 0.275
50.00 0.451
25.00 0.531
12.50 0.977
6.25 1.439
3.13 1.813
0.00 2.316

Precision

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant Anti-PLP1 and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-PLP1 in samples.
Matrix Recovery range Average
serum(n=5) 78-96% 87%
EDTA plasma(n=5) 80-95% 87%
Heparin plasma(n=5) 78-92% 85%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-PLP1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 86-95% 91-106% 87-100% 95-101%
EDTA plasma(n=5) 95-102% 83-97% 88-96% 96-103%
Heparin plasma(n=5) 85-101% 84-98% 85-93% 86-98%